Covid-19: Kenya gets drugs from India
Health & Science
By
Anyango Otieno
| May 12, 2020
India has allowed one-time export of Hydroxychloroquine Sulphate USP 200 mg to Kenya to support Kenya in its fight against Covid-19 pandemic.
The country ordered a one-off consignment of 379,000 tablets of the drug from India after the Asian nation partially lifted a ban on the export of the drug last month.
The deal followed a telephone conversation between Foreign Affairs secretary Raychelle Omamo and Indian External Affairs minister Subrahmanyam Jaishankar.
“In keeping with excellent bilateral ties, as a special gesture, India has allowed one-time export of prohibited Hydroxychloroquine Sulphate USP 200 mg (379,000 tablets) to Kenya to support Government of Kenya in its fight against COVID19 pandemic,” read a communique from the Indian High Commission.
In addition, the second tranche of essential medicines (HIV medicines worth Sh163,686,600) has also arrived in Nairobi, as gift from Government of India.
READ MORE
The true impact of Iran-US war on the Kenyan economy
How personalised developments are reshaping local property market
Government tightens oversight on Saccos to safeguard members' deposits
KRA targets 5 million tax filers with WhatsApp option
Apple at 50: eight technology leaps that changed our world
Kenya's push to maximise Sh95 billion circular economy
Interest income, foreign exchange trade: Where banks cut earnings in 2025
Domestic workers push for rights as Kenya eyes key labour reforms
The first tranche of essential medicines, as part of India’s commitment to provide essential medicines to the people of Kenya, was delivered in July 2018.
Government of India has also committed to gift chlorine in the form of Calcium Hypochlorite (HTH) for water treatment as requested by Government of Kenya.